Article Details

Adaptimmune, seeking to stay afloat, sells off cell therapies | BioPharma Dive

Retrieved on: 2025-07-28 20:33:50

Tags for this article:

Click the tags to see associated articles and topics

Adaptimmune, seeking to stay afloat, sells off cell therapies | BioPharma Dive. View article details on hiswai:

Excerpt

A deal with US WorldMeds includes the FDA-approved TCR therapy Tecelra and two clinical-stage cancer medicines.

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo